Aptevo Therapeutics Inc.
APVO· Nasdaq
APVOAptevo Therapeutics Inc.
Filed Nov 14, 2016 · 10-Q · 45 days after period end · 0001564590-16-029292
| Metric | Q3 2016 | Q3 2015 |
|---|---|---|
| Revenue | $2.82M | $6.56M |
| Net Income | -$71.74M | -$12.68M |
| EPS Diluted | -$3.55 | -$0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 14, 2016 · 45 d after period end
